医院
青岛大学附属医院The Affiliated Hospital of Qingdao University
概览
仅为已发布的数值,每一个都取自本页所依据的记录。其背后的名单见下方章节。
-
复旦大学医院排行榜 A++ 综合榜,2023
-
已发表研究 16 我们为该医院保存的 PubMed 记录(每家医院最新二十条)
-
已登记研究 25 我们为该医院保存的记录,按注册原样
排名与认证
这些名单由运营它们的机构发布,而非本站。每一行都带其发布年份与来源链接;这不是付费或推广位。
复旦大学医院排行榜
| 项目 | 名次/层级 | 年份 | 口径 | 来源 |
|---|---|---|---|---|
| 综合榜 | A++ | 2023 | 仅列层级;同一层级内的医院之间不排序 | https://rank.cn-healthcare.com/fudan/national-general |
面向境外患者
只有在我们持有相应记录时,这里才会出现一行。缺失的行尚未核实——联系我们,我们会向医院提出该问题。
医院详情
- 中文名
- 青岛大学附属医院
- 英文名
- The Affiliated Hospital of Qingdao University
以中文写出的数值按来源原样引用。
等级名单的依据是官方名单发布时所依据的日期或评审批次;按来源的语言引用。
该疾病的证据
依据官方公开数据来源筛选
-
Colorectal cancer
已发表研究
- Retraction Notice to: “Mitigating Bias in Colorectal Cancer Research: Assessing the Limitations of the Cox Proportional Hazards Model and Considering Alternative Methods” Gastroenterology 2025;168:1197-1198. Gastroenterology, 2026
- Large language model treatment-pathway outputs based on structured clinical text in mid- and low rectal cancer: Concordance with multidisciplinary team decisions and features associated with discordance. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2026
PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。
-
Breast cancer
已发表研究
- A multimodal cross-temporal fusion system for complementary evaluation of neoadjuvant chemotherapy in breast cancer. European journal of radiology, 2026
- Plasma chlorinated paraffin mixtures and breast cancer: Nonlinear patterns in an exploratory case-control study. Environmental pollution (Barking, Essex : 1987), 2026
另有 4 项已发表研究
PubMed 收录了 6 篇关于该疾病、并提及这家医院的论文。
-
Lung cancer
已发表研究
- Nanocarrier-Mediated Nucleic Acid Therapy in Non-Small Cell Lung Cancer: Converging Delivery Barriers, Resistance Reversal, and Clinical Translation. Current gene therapy, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
-
Liver cancer
已发表研究
- SERBP1 promoter single nucleotide polymorphism (SNP) rs3762314: a genetic susceptibility biomarker promoting malignant phenotype in hepatocellular carcinoma. Biochemical and biophysical research communications, 2026
- Oncolytic virus-based immunotherapy for hepatocellular carcinoma: Strategies for enhanced efficacy and clinical application. Critical reviews in oncology/hematology, 2026
PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。
-
Cervical cancer
已发表研究
- Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review. Human vaccines & immunotherapeutics, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
-
Stomach cancer
已发表研究
- Engineering a Redox-Responsive Bimolecular Prodrug for Targeted Gastric Cancer Combination Therapy: Design, Synthesis, and In Vivo Evaluation. Antioxidants (Basel, Switzerland), 2026
- Solasonine inhibits growth of gastric cancer by targeting FTL-mediated ferroptosis. Bioorganic chemistry, 2026
另有 1 项已发表研究
PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。
-
Thyroid cancer
已发表研究
- Engrailed-1 Promotes Tumor Progression and Metastasis in Papillary Thyroid Cancer. Cancer biotherapy & radiopharmaceuticals, 2026
PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。
来源与证据
- 来源 URL
- https://rank.cn-healthcare.com/fudan/national-general
- 来源协议
- https
- 来源类型
- 第三方汇编
- 证据等级
- B ——医院自我声明或权威媒体
- 获取日期
- 2026-09-24